| Literature DB >> 28195172 |
Hewa M S Wasana1, Gamage D R K Perera2, Panduka De S Gunawardena3, Palika S Fernando4, Jayasundera Bandara1.
Abstract
Despite WHO standards, waterborne diseases among the human being are rising alarmingly. It is known that the prolong exposure to contaminated water has major impact on public health. The effect of chemical contaminations in drinking water on human being is found to be chronic rather than acute and hence can be defined "consumption of contaminated drinking water could be a silent killer". As the WHO recommended water quality standards are only for individual element and synergic effects of trace metals and anions have not been considered, investigation of synergic effects of trace metals and anions and their effect on human being is of prime important research. By an animal trial, we investigated the synergic effect(s) of heavy metals, aluminium, arsenic, fluoride and hardness in drinking water on kidney tissues of mice. Our investigation strongly suggests existing of a synergic effect especially among Cd, F and hardness of water which could lead to severe kidney damage in mice, even at WHO maximum recommended levels. Hence, the synergic effect(s) of trace metals, fluoride and hardness present in drinking water should be investigated meticulously when stipulating the water quality at WHO maximum recommended levels.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28195172 PMCID: PMC5307334 DOI: 10.1038/srep42516
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Histopathological evaluation of renal tissues in; (a) G1-Intact tubules, pointer-glomeruli and interstitium (H&E × 100). G2-i Tubular interstitial lesions, a-Formation of fibrous bands, b-Apoptotic cells with nuclear pyknosis, c- Tubular atrophy in proximal convoluted tubule (PCT), d, Pointer – Degeneration and necrosis of PCT (H&E × 100). G2-ii-Initiation of glomerular sclerosis, e-Fibrosis of Bow man capsules. Pointer–thicken Bow man capsule (H&E × 100). G2-iii-Hemorrhages at cortico-medullary area (H&E × 100). G2-iv-Interstitial inflammatory cell infiltration at renal cortex, f-infiltrated mononuclear inflammatory cells (H&E × 100). G3-i -interstitial fibrosis (blue colour, pointer) (MT × 100). G3-iiTubular lesions, g-Tubular atrophy (loss of brush borders with clear lumen in PTC, h-Degenerated and necrotic areas of PCT, i-Apoptosis of tubular epithelial cells with pyknotic nuclei, j-Hyperemic renal capillaries (H&E × 100). G3-iii-pointer-hemorrhagic area (H&E × 40). G3-iv-k-Global glomerular sclerosis (Blue colour), m-interstitial fibrosis (blue colour) (MT × 100). G3-v-Reduced functional renal tissue density and interstitial fibrosis, n-Mononuclear inflammatory cell infiltration, o-Tubular atrophy in PCT, p-Protein cast in a tubular lumen (H&E × 100). G4-Tubular lesions, q-Apoptotic cells with pyknotic nuclei PCT, r-Tubular atrophy (brush borders are lost with clear lumen) in PCT, s-degenerated tubular epithelial cell in a PCT, t-Necrotic area of a PCT (H&E × 100). G5-i,u-Tubular atrophy. v-Cell infiltration, w–Apoptotic cell with nuclear pyknosis, pointer-intact glomerulus (H&E × 40). (b) G5-ii, a-Hyperemic capillaries (H&E × 100). G6-i, b-Tubular atrophy in PCT (loss of brush borders with clear lumen), c-Mononuclear inflammatory cell infiltration, d-replacement of renal tissue with fibrous tissue in renal cortex (H&E × 100). G6-ii, pointer–PCT undergoing atrophy (loss of brush borders with clearing of the lumen) e-Degeneration and necrosis of tubules, f-Apoptotic cell with nuclear pyknosis (H&E × 40).G7, g-Apoptotic tubular epithelial cell, h-Hyperemic capillaries at cortical area, i-Initial stages of fibrosis, j-Degeneration and necrosis of PCT (H&E × 40). G8-i, k-Hyperemic capillaries (H&E × 100).G8-ii,l-Apoptotic cells of a PCT. G8-iii, m-Tubular degeneration and necrosis (MT × 40). G9-i, n-Tubular atrophy of a PCT, o-Apoptotic cells with nuclear pyknosis, (H&E × 100). G9-ii, p- Apoptotic cell. Q-Degeneration and necrosis of PCT, r-Hyperemic capillaries. (H&E × 100). G10, s-Tubular atrophy, t-Apoptosis, u-Degenerated cell of a PCT, v-Mononuclear cell infiltration (H&E × 100). G11, w-Apoptotic tubular epithelial cell, x-Tubular atrophy of PTC, y-Interstitial fibrosis, y-i-Hyperemic capillaries (H&E × 40).G12, z- Apoptotic cell, zi-Tubular atrophy of a PCT, Pointer-Mononuclear cell infiltration, zii-Cell degeneration and necrosis (H&E × 100).
Average severity % of the treatment groups and control group for considered lesion for CKD.
| Lesion type | Severity level | Groups | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G-1 | G-2 | G-3 | G-4 | G-5 | G-6 | G-7 | G-8 | G-9 | G-10 | G-11 | G-12 | ||
| 1) Interstitial fibrosis (ci) | ci0 | 100.0 | 0.0 | 0.0 | 22.2 | 0.0 | 0.0 | 11.1 | 0.0 | 0.0 | 90.0 | 12.5 | 33.3 |
| ci1 | 0.0 | 22.2 | 0.0 | 77.8 | 80.0 | 75.0 | 89.9 | 100.0 | 100.0 | 10.0 | 87.5 | 66.7 | |
| ci2 | 0.0 | 77.8 | 25.0 | 0.0 | 20.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| ci3 | 0.0 | 0.0 | 75.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 2) Mononuclear cell interstitial infiltration (i) | i0 | 80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 0.0 | 0.0 | 20.0 | 33.3 | 0.0 | 0.0 |
| i1 | 20.0 | 55.6 | 33.3 | 89.9 | 37.5 | 80.0 | 77.8 | 87.5 | 80.0 | 66.7 | 37.5 | 66.7 | |
| i2 | 0.0 | 44.4 | 66.7 | 11.1 | 62.5 | 0.0 | 22.2 | 12.5 | 0.0 | 0.0 | 62.5 | 33.3 | |
| 3) Tubular atrophy (ct) | ct0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.5 | 20.0 | 0.0 | 0.0 |
| ct1 | 0.0 | 0.0 | 0.0 | 22.2 | 20.0 | 25.0 | 66.7 | 37.5 | 87.5 | 80.0 | 0.0 | 55.6 | |
| ct2 | 0.0 | 62.5 | 25.0 | 77.8 | 80.0 | 75.0 | 33.3 | 62.5 | 0.0 | 0.0 | 89.9 | 44.4 | |
| ct3 | 0.0 | 37.5 | 75.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 11.1 | 0.0 | |
| 4) Global glomerular sclerosis score (%) | 0 | 100.0 | 100.0 | 0.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| 1–40 | 0.0 | 0.0 | 37.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 41–65 | 0.0 | 0.0 | 62.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 5) Focal glomerular sclerosis score (%) | 0 | 100.0 | 77.8 | 0.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| 1–20 | 0.0 | 22.2 | 37.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 21–50 | 0.0 | 0.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| >50 | 0.0 | 0.0 | 37.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sample size at the end | 10 | 9 | 8 | 9 | 8 | 8 | 9 | 8 | 8 | 10 | 8 | 9 | |
Figure 2Severity increment of the CKD lesions of mice in test groups (2–12) and control group (1).
(Lesions;1. Interstitial fibrosis 2. Mono-nuclear cell interstitial infiltration 3.Tubular atrophy, 4. Focal glomerular sclerosis and 5. Global glomerular sclerosis).